PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Doctors at Omotesando Helene Clinic Publish New Study on Long-Term Safety Surveillance Following High-Dose Intravenous MSC Administration
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
2026-05-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change
2026-05-28T    Banking/Financial Service   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY
2026-05-28T    Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.